Form 4: RxSight CFO Shelley Thunen Executes Stock Option, Acquires Shares
SEC Form 4
Shelley Thunen, CFO of RxSight, Inc., exercised stock options and acquired 16,505 shares of common stock at a price of $4.34 on July 15, 2024.
Summary
- On July 15, 2024, Shelley Thunen, the Co-President and Chief Financial Officer of RxSight, Inc. (RXST), executed stock options.
- Thunen acquired 16,505 shares of common stock at a price of $4.34 per share.
- Following the transaction, Thunen directly owns 30,443 shares of RxSight common stock.
- The transactions were made pursuant to the Issuer's 2015 Equity Incentive Plan, as amended.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard regulatory filing about stock option exercises.
Industry Context
This is a routine Form 4 filing, indicating insider transactions. It's common for executives to receive and exercise stock options as part of their compensation.
Stakeholder Impact
- The transaction could have a minor impact on shareholders due to the change in ownership, but it's unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| 10/27/2020 | Date exercisable for stock options |
| 02/24/2021 | Date exercisable for stock options |
| 03/13/2027 | Expiration date for stock options |
| 10/26/2026 | Expiration date for stock options |
| June 13, 2024 | Date of Power of Attorney execution |
| 07/15/2024 | Date of stock option exercise and share acquisition |
| 07/16/2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.